259 related articles for article (PubMed ID: 9539778)
21. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
23. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
24. No evidence of genetic heterogeneity in Crouzon craniofacial dysostosis.
Ma HW; Lajeunie E; Le Merrer M; de Parseval N; Serville F; Weissenbach J; Munnich A; Renier D
Hum Genet; 1995 Dec; 96(6):731-5. PubMed ID: 8522336
[TBL] [Abstract][Full Text] [Related]
25. Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome.
Steinberger D; Mulliken JB; Müller U
Hum Genet; 1995 Jul; 96(1):113-5. PubMed ID: 7607643
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome.
Cornejo-Roldan LR; Roessler E; Muenke M
Hum Genet; 1999 May; 104(5):425-31. PubMed ID: 10394936
[TBL] [Abstract][Full Text] [Related]
27. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome.
Przylepa KA; Paznekas W; Zhang M; Golabi M; Bias W; Bamshad MJ; Carey JC; Hall BD; Stevenson R; Orlow S; Cohen MM; Jabs EW
Nat Genet; 1996 Aug; 13(4):492-4. PubMed ID: 8696350
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.
Reardon W; Winter RM; Rutland P; Pulleyn LJ; Jones BM; Malcolm S
Nat Genet; 1994 Sep; 8(1):98-103. PubMed ID: 7987400
[TBL] [Abstract][Full Text] [Related]
30. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains.
Neilson KM; Friesel R
J Biol Chem; 1996 Oct; 271(40):25049-57. PubMed ID: 8798788
[TBL] [Abstract][Full Text] [Related]
31. A novel insertion in the FGFR2 gene in a patient with Crouzon phenotype and sacrococcygeal tail.
Lapunzina P; Fernández A; Sánchez Romero JM; Delicado A; Sáenz de Pipaon M; López Pajares I; Molano J
Birth Defects Res A Clin Mol Teratol; 2005 Jan; 73(1):61-4. PubMed ID: 15602758
[TBL] [Abstract][Full Text] [Related]
32. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.
Bellus GA; Gaudenz K; Zackai EH; Clarke LA; Szabo J; Francomano CA; Muenke M
Nat Genet; 1996 Oct; 14(2):174-6. PubMed ID: 8841188
[TBL] [Abstract][Full Text] [Related]
33. Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case.
Schaefer F; Anderson C; Can B; Say B
Am J Med Genet; 1998 Jan; 75(3):252-5. PubMed ID: 9475591
[TBL] [Abstract][Full Text] [Related]
34. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
[TBL] [Abstract][Full Text] [Related]
35. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers.
Jang JH; Shin KH; Park JG
Cancer Res; 2001 May; 61(9):3541-3. PubMed ID: 11325814
[TBL] [Abstract][Full Text] [Related]
36. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
[TBL] [Abstract][Full Text] [Related]
37. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
38. A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome.
de Ravel TJ; Taylor IB; Van Oostveldt AJ; Fryns JP; Wilkie AO
Eur J Hum Genet; 2005 Apr; 13(4):503-5. PubMed ID: 15523492
[TBL] [Abstract][Full Text] [Related]
39. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
Adar R; Monsonego-Ornan E; David P; Yayon A
J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
[TBL] [Abstract][Full Text] [Related]
40. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
